樂觀
$1.96
情境價格
$2.010
+0.094 (+4.69%)收盤時
Meiwu Technology Co Ltd is a holding company primarily engaged in functional skincare business. The Company operating through three segments. The Skincare Products & Service segment focuses on functional skincare formula development, skincare training services, and sales of skincare products. The Quality Food Products Platform segment primarily sells meal replacement drinks, compressed candies, and other food products to customers through an online platform. The Technical Services division mainly provides technical solutions to clients. The Company primarily operates in the domestic market.
Meiwu Technology Co Ltd (WNW) is not a good buy right now due to its extremely low current price of $1.95, a year-to-date change of -98.67%, and a very low RSI of 21.358 indicating oversold conditions. The stock has also experienced a significant decline of 98.78% over the past year, which raises concerns about its long-term viability.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Meiwu Technology Announces 1-for-100 Reverse Stock Split

Meiwu Technology Announces Reverse Stock Split

Meiwu Technology Signs Share Purchase Agreement

Meiwu Technology Announces Direct Offering of 6.99 Million Shares

Meiwu Technology Announces $14 Million Direct Offering
Meiwu Technology Co Ltd is a holding company primarily engaged in functional skincare business. The Company operating through three segments. The Skincare Products & Service segment focuses on functional skincare formula development, skincare training services, and sales of skincare products. The Quality Food Products Platform segment primarily sells meal replacement drinks, compressed candies, and other food products to customers through an online platform. The Technical Services division mainly provides technical solutions to clients. The Company primarily operates in the domestic market. It operates in the Consumer Cyclicals sector (CATALOG AND MAIL- ORDER HOUSES industry).
Meiwu Technology Co Ltd (WNW) is not a good buy right now due to its extremely low current price of $1.95, a year-to-date change of -98.67%, and a very low RSI of 21.358 indicating oversold conditions. The stock has also experienced a significant decline of 98.78% over the past year, which raises concerns about its long-term viability.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。